Spots Global Cancer Trial Database for NCCH2006/MK010 Trial (FORTUNE Trial)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: NCCH2006/MK010 Trial (FORTUNE Trial)
Official Title: Multicenter Investigator-initiated Phase II Trial of E7090 in Patients With Advanced or Recurrent Solid Tumor With Fibroblast Growth Factor Receptor (FGFR) Gene Alteration (FORTUNE Trial)
Study ID: NCT04962867
Interventions
Study Description
Brief Summary: This is a single-arm, open-label, multicenter, investigator-initiated Phase 2 trial to evaluate the efficacy and safety of E7090 in patients with advanced or recurrent solid tumors harboring FGFR genetic alterations (including fusion, mutation, amplification).
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tohoku University Hospital, Aoba-ku, Sendai, Miyagi, , Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, , Japan
Kyushu University Hospital, Higashi-Ku, Fukuoka, , Japan
Hokkaido University Hospital, Kita-Ku, Sapporo, Hokkaido, , Japan
Kyoto University Hospital, Sakyo-ku, Kyoto, , Japan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
